Destination Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
3,997
-700
-15% -$92.2K 0.01% 215
2026
Q1
$655K Buy
4,697
+1,601
+52% +$224K 0.02% 182
2025
Q4
$380K Sell
3,096
-396
-11% -$48.1K 0.01% 226
2025
Q3
$388K Buy
3,492
+176
+5% +$20K 0.01% 203
2025
Q2
$368K Buy
3,316
+117
+4% +$12.5K 0.01% 201
2025
Q1
$358K Sell
3,199
-720
-18% -$74.3K 0.01% 195
2024
Q4
$362K Buy
+3,919
New +$353K 0.01% 186
2019
Q3
Sell
-2,059
Closed -$139K 266
2019
Q2
$139K Sell
2,059
-4,528
-69% -$298K 0.01% 155
2019
Q1
$428K Sell
6,587
-136
-2% -$9.04K 0.02% 115
2018
Q4
$421K Sell
6,723
-1,683
-20% -$118K 0.03% 114
2018
Q3
$649K Buy
8,406
+275
+3% +$20.8K 0.04% 110
2018
Q2
$576K Buy
8,131
+7,631
+1,526% +$539K 0.03% 106
2018
Q1
$38K Buy
+500
New +$39.7K ﹤0.01% 283
2017
Q3
Sell
-3,557
Closed -$252K 153
2017
Q2
$252K Sell
3,557
-3,721
-51% -$248K 0.02% 142
2017
Q1
$494K Buy
+7,278
New +$512K 0.03% 109

Other funds holding GILD

Destination Wealth Management's GILD Position: Q2 2026 in Review

Destination Wealth Management reduced its Gilead Sciences (GILD) stake by 15% in Q2 2026, selling an estimated $92.2K and leaving 3,997 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #215.

Destination Wealth Management first reported a position in GILD in Q1 2017 and has held it in 15 quarters since. The position peaked at $655K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Destination Wealth Management held 3,997 shares of Gilead Sciences worth $505K as of Q2 2026.
  • Destination Wealth Management sold 700 Gilead Sciences shares in Q2 2026, an estimated $92.2K.
  • Gilead Sciences made up 0.01% of Destination Wealth Management's portfolio in Q2 2026, its #215 holding.
  • Destination Wealth Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 15 quarters since.
  • Destination Wealth Management's Gilead Sciences position peaked at $655K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Destination Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.